A 72-year-old with HFrEF asks about SGLT2 inhibitors. Which statement aligns with guidelines?...

Question

A 72-year-old with HFrEF asks about SGLT2 inhibitors. Which statement aligns with guidelines?

Accepted Answer

SGLT2 inhibitors reduce HF hospitalization and CV death in HFrEF regardless of diabetes

Answer

SGLT2 inhibitors are only for diabetes

Answer

SGLT2 inhibitors worsen kidney outcomes in CKD

Answer

Use only if EF

Answer

Require eGFR ≥90 to start

"us-abim MCQ (SBA): SGLT2 in HFrEF